Sandbox Reserved 339
From Proteopedia
(Difference between revisions)
| Line 9: | Line 9: | ||
===Sub Title=== | ===Sub Title=== | ||
====Sub Sub Title==== | ====Sub Sub Title==== | ||
| - | Policosanol, a well-defined mixture of very long chain primary alcohols that is available as a nutraceutical product, has been reported to lower blood cholesterol levels.<ref name="placeholder"> 21359855 </ref> | + | Policosanol, a well-defined mixture of very long chain primary alcohols that is available as a nutraceutical product, has been reported to lower blood cholesterol levels.<ref name="placeholder"> PMID 21359855 </ref> |
In summary, this study provides the platform for further structure-guided design hypotheses of novel drug candidates with higher affinity and selectivity.<ref name="Steuber"> 17368668 </ref> | In summary, this study provides the platform for further structure-guided design hypotheses of novel drug candidates with higher affinity and selectivity.<ref name="Steuber"> 17368668 </ref> | ||
Revision as of 03:01, 3 March 2011
| This Sandbox is Reserved from January 10, 2010, through April 10, 2011 for use in BCMB 307-Proteins course taught by Andrea Gorrell at the University of Northern British Columbia, Prince George, BC, Canada. |
To get started:
More help: Help:Editing |
Contents |
Aldose Reductase (2IKH)
|
Title
Sub Title
Sub Sub Title
Policosanol, a well-defined mixture of very long chain primary alcohols that is available as a nutraceutical product, has been reported to lower blood cholesterol levels.[1] In summary, this study provides the platform for further structure-guided design hypotheses of novel drug candidates with higher affinity and selectivity.[2]
Title
References
- ↑ Banerjee S, Ghoshal S, Porter TD. Activation of AMP-kinase by Policosanol Requires Peroxisomal Metabolism. Lipids. 2011 Feb 27. PMID:21359855 doi:10.1007/s11745-011-3540-6
- ↑ 17368668
